Diagnostic microbiology and infectious disease · 2026
Evaluation of a 16S rRNA real-time PCR assay for detection of mycobacterium tuberculosis in comparison with GeneXpert MTB/RIF in a Vietnam hospital.
СтатьяСравнительное исследованиеОценочное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dao Bang Ngoc, Ta Thang Ba, Luong Thuc Cong, Pham Nhung Thi Kim, Van Nguyen Dung, Le Hien Thi Dieu, Nguyen Cong Hai, Vo Thuy Thi Bich
Аннотация
PURPOSE: Tuberculosis remains a major public health challenge in Vietnam, requiring timely and accurate diagnosis. This study aimed to evaluate the clinical performance of a simple real-time PCR assay targeting the 16S rRNA gene of Mycobacterium tuberculosis, with emphasis on its applicability in routine hospital conditions.
METHODS: A cross-sectional study was conducted at Military Hospital 103 (during 2022-2023) involving 60 newly diagnosed pulmonary TB patients (30 Acid-Fast Bacillus (AFB)-positive, 30 AFB-negative), 30 community-acquired pneumonia patients, and 30 Mycobacterium tuberculosis (MTB) plus 30 non-tuberculous mycobacteria (NTM) isolates as controls. Depending on the study group and sample availability, specimens were subjected to MGIT culture, AFB smear microscopy, GeneXpert MTB/RIF, and 16S rRNA real-time PCR according to the study protocol and routine clinical workflow. Diagnostic performance was assessed using MGIT culture as the reference standard.
RESULTS: The 16S rRNA PCR assay showed 100% sensitivity and specificity in control isolates. In clinical specimens, sensitivity and specificity were 100% and 100% in AFB-positive patients, 83.3% and 100% in AFB-negative patients, and 91.7% and 100% overall. GeneXpert MTB/RIF showed a sensitivity of 86.7% and specificity of 100% among tested samples. Notably, reduced GeneXpert sensitivity was observed in a subset of blood-contaminated specimens, whereas the 16S rRNA assay maintained consistent detection performance.
CONCLUSION: The 16S rRNA real-time PCR assay demonstrated high diagnostic accuracy across different clinical subgroups and specimen types under routine laboratory conditions. While not introducing a novel molecular target, this approach showed potential as a complementary diagnostic tool, particularly in settings where access to automated molecular platforms is limited or where specimen quality may affect test performance.
METHODS: A cross-sectional study was conducted at Military Hospital 103 (during 2022-2023) involving 60 newly diagnosed pulmonary TB patients (30 Acid-Fast Bacillus (AFB)-positive, 30 AFB-negative), 30 community-acquired pneumonia patients, and 30 Mycobacterium tuberculosis (MTB) plus 30 non-tuberculous mycobacteria (NTM) isolates as controls. Depending on the study group and sample availability, specimens were subjected to MGIT culture, AFB smear microscopy, GeneXpert MTB/RIF, and 16S rRNA real-time PCR according to the study protocol and routine clinical workflow. Diagnostic performance was assessed using MGIT culture as the reference standard.
RESULTS: The 16S rRNA PCR assay showed 100% sensitivity and specificity in control isolates. In clinical specimens, sensitivity and specificity were 100% and 100% in AFB-positive patients, 83.3% and 100% in AFB-negative patients, and 91.7% and 100% overall. GeneXpert MTB/RIF showed a sensitivity of 86.7% and specificity of 100% among tested samples. Notably, reduced GeneXpert sensitivity was observed in a subset of blood-contaminated specimens, whereas the 16S rRNA assay maintained consistent detection performance.
CONCLUSION: The 16S rRNA real-time PCR assay demonstrated high diagnostic accuracy across different clinical subgroups and specimen types under routine laboratory conditions. While not introducing a novel molecular target, this approach showed potential as a complementary diagnostic tool, particularly in settings where access to automated molecular platforms is limited or where specimen quality may affect test performance.